BACE inhibitor treatment of mice induces hyperactivity in a Seizure-related gene 6 family dependent manner without altering learning and memory
Abstract BACE inhibitors, which decrease BACE1 (β-secretase 1) cleavage of the amyloid precursor protein, are a potential treatment for Alzheimer’s disease. Clinical trials using BACE inhibitors have reported a lack of positive effect on patient symptoms and, in some cases, have led to increased adv...
Guardado en:
Autores principales: | A. Nash, H. J. M. Gijsen, B. J. Hrupka, K. S.-L. Teng, S. F. Lichtenthaler, H. Takeshima, J. M. Gunnersen, K. M. Munro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30fc73a123fe4f83943a0c12121c8a83 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Attachment Representations in Children with and without Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Tycho J. Dekkers, et al.
Publicado: (2021) -
The beta secretase BACE1 regulates the expression of insulin receptor in the liver
por: Paul J. Meakin, et al.
Publicado: (2018) -
Complex prospective memory in adults with attention deficit hyperactivity disorder.
por: Anselm B M Fuermaier, et al.
Publicado: (2013) -
Sleep Disturbances in Patients with Nonepileptic Seizures
por: Vanek J, et al.
Publicado: (2021) -
Activation of PKR causes amyloid ß-peptide accumulation via de-repression of BACE1 expression.
por: Gerard Ill-Raga, et al.
Publicado: (2011)